Clinical Trials
33
Active:9
Completed:21
Trial Phases
4 Phases
Phase 1:15
Phase 2:5
Phase 4:4
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (27 trials with phase data)• Click on a phase to view related trials
Phase 1
15 (55.6%)Phase 2
5 (18.5%)Phase 4
4 (14.8%)Not Applicable
3 (11.1%)Sitagliptin and the Risk for Hypoglycaemia in Type 2 Diabetes Patients
- First Posted Date
- 2017-12-02
- Last Posted Date
- 2021-02-21
- Lead Sponsor
- Profil Institut für Stoffwechselforschung GmbH
- Target Recruit Count
- 20
- Registration Number
- NCT03359590
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
Empagliflozin and Sympathetic Nerve Traffic
Phase 4
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- First Posted Date
- 2017-08-21
- Last Posted Date
- 2020-07-14
- Lead Sponsor
- Profil Institut für Stoffwechselforschung GmbH
- Target Recruit Count
- 75
- Registration Number
- NCT03254849
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, North Rhine-Westphalia, Germany
Validation of the Doubly Labelled Water Method in Subjects With Type 2 Diabetes Mellitus
Not Applicable
Completed
- Conditions
- Diabetes
- First Posted Date
- 2015-08-10
- Last Posted Date
- 2021-12-29
- Lead Sponsor
- Profil Institut für Stoffwechselforschung GmbH
- Target Recruit Count
- 35
- Registration Number
- NCT02518581
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
Effects of Linagliptin in Addition to Empagliflozin on Islet Cell Physiology
Phase 4
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- First Posted Date
- 2015-03-30
- Last Posted Date
- 2016-02-24
- Lead Sponsor
- Profil Institut für Stoffwechselforschung GmbH
- Target Recruit Count
- 89
- Registration Number
- NCT02401880
- Locations
- 🇩🇪
Profil Mainz GmbH & Co. KG, Mainz, Germany
🇩🇪Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion
- First Posted Date
- 2014-09-04
- Last Posted Date
- 2018-10-17
- Lead Sponsor
- Profil Institut für Stoffwechselforschung GmbH
- Target Recruit Count
- 109
- Registration Number
- NCT02231658
- Locations
- 🇩🇪
St. Josef-Hospital, Universitätsklinik, Bochum, Germany
🇩🇪Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
News
No news found